Publications by authors named "V Hari Sai Priya"
Background: Kidney transplant recipients are uniquely exposed to the disordered bone metabolism associated with chronic kidney disease beginning before transplantation followed by chronic corticosteroid use after transplantation. Previous efforts to synthesize the rapidly accruing evidence regarding estimation and management of fracture risk in kidney transplant recipients are outdated and incomplete.
Objective: To synthesize the evidence informing the overall incidence, patient-specific risk prediction, and methods of prevention of fractures in patient living with a kidney transplant.
In the present study, ohmic heating system was developed for the pasteurization of liquid egg white. A batch reactor system was designed with a capacity of 100 ml and operated at varied gradients of voltage (20, 15, 10 V/cm), frequencies (10, 55, 100 Hz), holding times (1, 2.5, 4 min) at two different waveforms (sine and square).
View Article and Find Full Text PDFGroundwater recharging and thus renewable groundwater supplies will experience considerable changes due to climate change. The present investigation focussed to evaluate the susceptibility of subsurface water in rapid developing textile industrial region of Southern India. To determine the aquifer's susceptibility, the DRASTIC-LU Remote sensing and GIS based vulnerability model was applied and the results were compared with human activity risk (HAR) analysis to ensure the water borne disease on human health.
View Article and Find Full Text PDFArticle Synopsis
- Alzheimer's disease (AD) is a progressive brain disorder that causes memory and cognitive decline, and while there are no cures, certain plant compounds, like those from Piper nigrum (black pepper), show promise as potential treatments.
- The research aimed to identify effective compounds from Piper nigrum through techniques like LCMS analysis and in silico studies to find substances that can target multiple areas related to AD treatment.
- The study identified 29 significant compounds and discovered 41 common gene targets related to AD, with one compound (P4) showing strong binding to key proteins associated with the disease, indicating its potential as an anti-AD drug with stable interactions.
Ciprofol (HSK3486) is a novel intravenous anaesthetic developed as an alternative to propofol, offering a safer and more effective option in anaesthesia. It works primarily by modulating the gamma-aminobutyric acid (GABA) receptors in the central nervous system, leading to sedation and hypnosis. Ciprofol's unique pharmacological properties include a rapid onset of action, shorter duration, and reduced cardiovascular and respiratory depression compared to propofol, making it particularly suitable for outpatient and day surgery procedures.
View Article and Find Full Text PDF